Retrovirus targeting by tropism restriction to melanoma cells

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6923-6929

  Martin, F ^a   Neil, S ^a   Kupsch, J ^b   Maurice, M ^c   Cosset, F L ^c   Collins, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOPROTEIN; LIPOSOME; MATRIX METALLOPROTEINASE; MELANOMA ANTIGEN; PROLINE; VIRUS RECEPTOR;

ARTICLE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; INFECTION; MELANOMA CELL; PRIORITY JOURNAL; RETROVIRUS; VIRION; VIRUS ENVELOPE;

EID: 0032775219     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6923-6929.1999     Document Type: Article

References (40)

1. Battini, J.-L., O. Danos, and J. M. Heard. 1995. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:113-719.
2. Bender, H., M. Grapow, A. Schomburg, U. Reinhold, and H. J. Biersack. 1997. Effects of diagnostic application of monoclonal antibody on survival in melanoma patients. Hybridoma 16:65-68.
3. Brooks, P. C., S. Stromblad, L. C. Sanders, T. L. von Schalscha, R. T. Aimes, W. G. Stetler-Stevenson, J. P. Quigley, and D. A. Cheresh. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:583-693.
4. Cosset, F.-L., F. J. Morling, Y. Takeuchi, R. A. Weiss, M. K. L. Collins, and S. J. Russell. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
5. Cosset, F.-L., Y. Takeuchi, J.-L. Battini, R. A. Weiss, and M. K. L. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
6. Eary, J. F., R. W. Schroff, P. G. Abrams, A. R. Fritzberg, A. C. Morgan, S. Kasina, J. M. Reno, A. Srinivasan, C. S. Woodhouse, D. S. Wilbur, et al. 1989. Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. J. Nuclear Med. 30:25-32.
7. Fielding, A. K., M. Maurice, F. J. Morling, F. L. Cosset, and S. J. Russell. 1998. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood 91: 1802-1809.
8. Hodgson, C. P., and F. Solaiman. 1996. Virosomes: cationic liposomes enhance retroviral transduction. Nat. Biotechnol. 14:339-342.
9. Kageshita, T., N. Kuriya, T. Ono, T. Horikoshi, M. Takahashi, G. Y. Wong, and S. Ferrone. 1993. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res. 53:2830-2833.
10. Kasahara, N., A. M. Dozy, and Y. W. Kan. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions [see comments]. Science 266:1373-1376.
11. Kavanaugh, M. P., and D. Kabat. 1996. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int. 49:959-963.
12. Konishi, H., T. Ochiya, K. A. Chester, R. H. Begent, T. Muto, T. Sugimura, and M. Terada. 1998. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody. Hum. Gene Ther. 9:235-248.
13. Kupsch, J. M., N. Tidman, J. A. Bishop, I. McKay, I. Leigh, and J. S. Crowe. 1995. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens. Melanoma Res. 5:403-411.
14. Lamki, L. M., A. A. Zukiwski, L. J. Shanken, S. S. Legha, R. S. Benjamin, C. E. Plager, D. F. Salk, R. W. Schrot, and J. L. Murray. 1990. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen. Cancer Res. 50:904s-908s.
15. Marin, M., D. Noël, S. Valsesia-Wittman, F. Brockly, M. Etienne-Julan, S. Russell, F.-L. Cosset, and M. Piechaczyk. 1996. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J. Virol. 70:2957-2962.
16. Martin, F., J. Kupsch, Y. Takeuchi, S. Russell, F. L. Cosset, and M. Collins. 1998. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. Hum. Gene Ther. 9:737-746.
17. Mittelman, A., Z. J. Chen, T. Kageshita, H. Yang, M. Yamada, P. Baskind, N. Goldberg, C. Puccio, T. Ahmed, Z. Arlin, et al. 1990. Active specific immunotherapy in patients with melanoma. A clinical trial with mouse anti-idiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies. J. Clin. Investig. 86:2136-2144. (Erratum, 87:757, 1991.)
18. Mittelman, A., Z. J. Chen, C. C. Liu, S. Hirai, and S. Ferrone. 1994. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res. 54:415-421.
19. Moderati, G., R. Brancato, G. Paganelli, P. Magnani, R. Pavoni, and F. Fazio. 1994. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results. Br. J. Ophthalmol. 78:19-23.
20. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
21. Natali, P. G., K. Imai, B. S. Wilson, A. Bigotti, R. Cavaliere, M. A. Pellegrino, and S. Ferrone. 1981. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J. Natl. Cancer Inst. 67:591-601.
22. Nilson, B. H., F. J. Morling, F. L. Cosset, and S. J. Russell. 1996. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther. 3:280-286.
23. Peng, K. W., F. J. Morling, F. L. Cosset, G. Murphy, and S. J. Russell. 1997. A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum. Gene Ther. 8:729-738.
24. Pizzato, M., E. D. Blair, A. McKnight, and Y. Takeuchi. Visualization of single retroviral particles and their binding to the cell using immunofluorescent microscopy. Submitted for publication.
25. Pluschke, G., M. Vanek, A. Evans, T. Dittmar, P. Schmid, P. Itin, E. J. Filardo, and R. A. Reisfeld. 1996. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Natl. Acad. Sci. USA 93:9710-9715.
26. Porter, C. D., K. V. Lukacs, G. Box, Y. Takeuchi, and M. K. L. Collins. 1998. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J. Virol. 72:4832-4840.
27. Ray, J. M., and W. G. Stetler-Stevenson. 1995. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J. 14:908-917.
28. Reiser, J., G. Harmison. S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
29. Schnierle, B. S., D. Moritz, M. Jeschke, and B. Groner. 1996, Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3:334-342.
30. Siccardi, A. G., G. L. Buraggi, L. Callegaro, G. Mariani, P. G. Natall, A. Abbati, M. Bestagno, V. Caputo, L. Mansi, R. Masi, et al. 1986. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res. 46:4817-4822.
31. Somia, N. V., M. Zoppe, and I. M. Verma. 1995. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc. Natl. Acad. Sci. USA 92:7570-7574.
32. Stack, M. S., and R. D. Gray. 1989. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide. J. Biol. Chem. 264:4277-4281.
33. Stetler-Stevenson, W. G., L. A. Liotta, and D. E. Kleiner, Jr. 1993. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1434-1441.
34. Takeuchi, Y., F.-L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. L. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:8001-8007.
35. Valsesia-Wittmann, S., F. J. Morling, T. Hatziioannou, S. J. Russell, and F. L. Cosset. 1997. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J. 16:1214-23. (Erratum, 16:4153, 1997.)
36. Valsesia-Wittmann, S., F. J. Morling, B. H. K. Nilson, Y. Takeuchi, S. J. Russell, and F.-L. Cosset 1996. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J. Virol. 70:2059-2064.
37. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retroviral entry, vol. 2. Plenum Press, New York, N.Y.
38. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
39. Yajima, T., T. Kanda, K. Yoshiike, and Y. Kitamura. 1998. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction. Hum. Gene Ther. 9:779-787.
40. Ye, Q. Z., L. L. Johnson, A. E. Yu, and D. Hupe. 1995. Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase. Biochemistry 34: 4702-4708.